0001062993-23-021522.txt : 20231128 0001062993-23-021522.hdr.sgml : 20231128 20231128162536 ACCESSION NUMBER: 0001062993-23-021522 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231127 FILED AS OF DATE: 20231128 DATE AS OF CHANGE: 20231128 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Campbell Michael Gerard CENTRAL INDEX KEY: 0001934174 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41403 FILM NUMBER: 231446798 MAIL ADDRESS: STREET 1: C/O COMERA LIFE SCIENCES HOLDINGS, INC. STREET 2: 12 GILL STREET, SUITE 4650 CITY: WOBURN STATE: MA ZIP: 01801 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Comera Life Sciences Holdings, Inc. CENTRAL INDEX KEY: 0001907685 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 874706968 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12 GILL STREET STREET 2: SUITE 4650 CITY: WOBURN STATE: MA ZIP: 01801 BUSINESS PHONE: (617)871-2101 MAIL ADDRESS: STREET 1: 12 GILL STREET STREET 2: SUITE 4650 CITY: WOBURN STATE: MA ZIP: 01801 4 1 form4.xml STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES X0508 4 2023-11-27 0001907685 Comera Life Sciences Holdings, Inc. CMRA 0001934174 Campbell Michael Gerard C/O COMERA LIFE SCIENCES HOLDINGS, INC. 12 GILL STREET, SUITE 4650 WOBURN MA 01801 0 1 0 0 EVP & CFO 0 Common Stock 2023-11-27 4 P 0 10000 0.0708 A 35000 D The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.0675 to $0.07125, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein. /s/ Ryan M. Rourke Reed, Attorney-in-Fact 2023-11-28